| P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy DM Fernández-Aroca, O Roche, S Sabater, R Pascual-Serra, ... Cancer Letters 451, 23-33, 2019 | 53 | 2019 |
| p38MAPK and chemotherapy: we always need to hear both sides of the story J García-Cano, O Roche, FJ Cimas, R Pascual-Serra, M Ortega-Muelas, ... Frontiers in cell and developmental biology 4, 69, 2016 | 52 | 2016 |
| Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion L Serrano-Oviedo, M Ortega-Muelas, J Garcia-Cano, ML Valero, ... PLoS One 13 (7), e0200878, 2018 | 28 | 2018 |
| P38β and cancer: The beginning of the road O Roche, DM Fernández-Aroca, E Arconada-Luque, N García-Flores, ... International Journal of Molecular Sciences 21 (20), 7524, 2020 | 20 | 2020 |
| E1a is an exogenous in vivo tumour suppressor FJ Cimas, JL Callejas-Valera, DC García-Olmo, J Hernández-Losa, ... Cancer Letters 399, 74-81, 2017 | 15 | 2017 |
| Effect of the aniline fragment in Pt (II) and Pt (IV) complexes as anti-proliferative agents. Standard reduction potential as a more reliable parameter for Pt (IV) compounds … J Leal, L Santos, DM Fernández-Aroca, JV Cuevas, MA Martínez, ... Journal of Inorganic Biochemistry 218, 111403, 2021 | 9 | 2021 |
| p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models R Pascual-Serra, DM Fernández-Aroca, S Sabater, O Roche, I Andrés, ... Radiotherapy and Oncology 156, 136-144, 2021 | 9 | 2021 |
| ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology M Ortega‐Muelas, O Roche, DM Fernández‐Aroca, JA Encinar, ... Journal of cellular and molecular medicine 25 (22), 10591-10603, 2021 | 5 | 2021 |
| MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study DM Fernández-Aroca, N García-Flores, S Frost, J Jiménez-Suárez, ... Clinical and Translational Radiation Oncology 41, 100649, 2023 | 2 | 2023 |
| ERK5 is a major determinant of chemical sarcomagenesis: Implications in human pathology E Arconada-Luque, J Jiménez-Suarez, R Pascual-Serra, SH Nam-Cha, ... Cancers 14 (14), 3509, 2022 | 2 | 2022 |
| P38 MAPK and Radiotherapy: Foes or Friends? N García-Flores, J Jiménez-Suárez, C Garnés-García, ... Cancers 15 (3), 861, 2023 | 1 | 2023 |
| The signaling axis CDK12-BRCA1 mediates dinaciclib associated radiosensitivity through p53-mediated cellular senescence. N Garcia-Flores, DM Fernandez-Aroca, C Garnes Garcia, ... bioRxiv, 2024.04. 25.590582, 2024 | | 2024 |
| Phylogenetic modeling of enhancer shifts in African mole-rats reveals regulatory changes associated with tissue-specific traits E Parey, D Fernandez-Aroca, S Frost, A Uribarren, TJ Park, M Zöttl, ... Genome Research 33 (9), 1513-1526, 2023 | | 2023 |
| Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents B Diaz de Greñu, DM Fernández-Aroca, JA Organero, G Durá, FA Jalón, ... JBIC Journal of Biological Inorganic Chemistry 28 (6), 531-547, 2023 | | 2023 |
| BS69 Characterisation of in vivo and in vitro models for epigenomic investigations of cardiac hypertrophy D Fernández-Aroca, S Frost, G Tikkas, A Rodriguez, A Tinker, D Villar Heart 109 (Suppl 3), A296-A296, 2023 | | 2023 |
| Estudio de las bases moleculares de la radiosensibilidad asociada a fármacos antitumorales DMF Aroca Universidad de Castilla-La Mancha, 2021 | | 2021 |
| Blockage of autophagic ux is associated with lymphocytosis and higher percentage of tumoral cells in chronic lymphocytic leukemia of B-cells O Roche, JR Romero-Macías, R Pascual-Serra, F Ruiz-Marcos, ... | | 2019 |
| Erk5 pathway is a new indirect target of sorafenib M Ortega-Muelas, L Muñoz-Martinez-Blanco, R Pascual-Serra, O Roche, ... | | 2018 |
| Palbociclib radiosensitizes colon and lung cancer cell lines in a p53-dependent manner DM Fernández-Aroca, O Roche, M Ortega-Muelas, R Pascual-Serra, ... | | 2018 |
